{
  "meta": {
    "id": "test46",
    "title": "RNA Corona Virus",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 49-year-old man presents in medicine OPD with complaints of fever, sore throat and myalgia. On examination, respiratory rate was 18/min, and oxygen saturation was 99%. In Chest X-ray, no abnormality was detected. He had a travel history from Beijing 1 week before, and the Physician suspects an RNA virus infection in the patient. He advised home care for patients in quarantine. Family members observe their symptoms for 14 days and should maintain a 1-2 meter distance from the patient. Which of the following RNA viruses have an incubation period of up to 14 days?",
      "options": [
        {
          "label": "A",
          "text": "Influenza virus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Parainfluenza virus",
          "correct": false
        },
        {
          "label": "C",
          "text": "SARS CoV-2",
          "correct": true
        },
        {
          "label": "D",
          "text": "Respiratory syncytial virus",
          "correct": false
        }
      ],
      "correct_answer": "C. SARS CoV-2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>SARS CoV-2 The above scenario suggests COVID-19/SARS-CoV-2 infection. The incubation period, which is the time between infection and onset of symptoms for COVID-19, is up to 14 days. Exposed individuals, in this case, should observe symptoms for 14 days. Also, they should follow infection control measures like Hand Hygiene, social distancing and frequent environmental cleaning. Incubation periods Virus Incubation period Influenza (OPTION A) 1-4 days Parainfluenza (OPTION B) 5-6 days Respiratory syncytial virus (OPTION D) 3-5 days Mumps 19 days COVID-19 (OPTION C) 14 days MERS 2-14 ays</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "07349ab5",
      "audio": ""
    },
    {
      "text": "What is the mode of transmission of SARS-CoV-2?",
      "options": [
        {
          "label": "A",
          "text": "Aerosol transmission",
          "correct": false
        },
        {
          "label": "B",
          "text": "Contact transmission",
          "correct": false
        },
        {
          "label": "C",
          "text": "Droplet transmission",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>All of the above Respiratory and contact routes usually transmit COVID-19. But can have aerosol transmission during aerosol-generating procedures like endotracheal intubation. So option D is correct. M odes of transmission for SARS-CoV-2, including contact, droplet, airborne, fomite, faecal-oral, bloodborne, mother-to-child, and animal-to-human transmission. Infection with SARS-CoV-2 primarily causes respiratory illness ranging from mild disease to severe disease and death, and some people infected with the virus never develop symptoms.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6e3bbfb9",
      "audio": ""
    },
    {
      "text": "A 26-year-old male was admitted to emergency high-grade fever and difficulty in breathing. The temperature was 102 F on examination, and oxygen saturation was 40%. CT chest was suggestive of bilateral lung consolidation. The medical officer ordered a Rapid Antigen test for COVID-19, which was positive. He has to do emergency endotracheal intubation for patients. Which of the following personal protective equipment prevents virus transmission from patient to doctor while doing intubation?",
      "options": [
        {
          "label": "A",
          "text": "Surgical/ Medical Mask",
          "correct": false
        },
        {
          "label": "B",
          "text": "N95 Mask",
          "correct": true
        },
        {
          "label": "C",
          "text": "Both a and b",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "B. N95 Mask",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>N95 Mask During procedures like endotracheal intubation, there is a risk of aerosol formation, smaller than droplets. In this case, the medical mask should be replaced by a N95 respirator.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. COVID-19 enters the respiratory tract via droplets formed during coughing and sneezing, which can be prevented by wearing a medical mask and social distancing. Options C and D. As N95 will be used in this case due to aerosol transmission risk, C and D are incorrect. Intubation chamber also helps prevent the transmission of covid to healthcare workers. However, it often requires greater skill, and video laryngoscope use is helpful.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "02ef2024",
      "audio": ""
    },
    {
      "text": "A 26-year-old male was admitted to emergency high-grade fever and difficulty in breathing. The temperature was 102 F on examination, and oxygen saturation was 40%. CT chest was suggestive of bilateral lung consolidation. The medical officer ordered a Rapid Antigen test for COVID-19, which was positive. Which of the following viral proteins helps in the attachment to Host cells?",
      "options": [
        {
          "label": "A",
          "text": "S protein",
          "correct": true
        },
        {
          "label": "B",
          "text": "N protein",
          "correct": false
        },
        {
          "label": "C",
          "text": "E protein",
          "correct": false
        },
        {
          "label": "D",
          "text": "RdRp protein",
          "correct": false
        }
      ],
      "correct_answer": "A. S protein",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>S protein SARS Cov-2 has 4 structural proteins (N, S, M and E) and 16 non-structural Proteins, e.g. RNA dependent RNA polymerase (RdRp) S pike (S) protei n helps in the attachment of viruses with target host cells. For virus entry, Spike protein is cleaved by host cell proteases enzyme, which produces the S1 subunit and S2 subunit. S1 binds with ACE-2 S2 helps in the fusion of the viral envelope with the host envelope.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B. Nucleocapsid (N) protein: present in Nucleocapsid surrounding +sense, ssRNA Option C. envelope (E) protein - transmembrane protein with ion-channel activity. M-Membrane glycoprotein- gives shape to the virus. Option D. Helps in replication.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1abbf6fd",
      "audio": ""
    },
    {
      "text": "A 49-year-old man presents in medicine OPD with fever, sore throat and myalgia complaints. On examination, respiratory rate was 18/min, and oxygen saturation was 99%. In Chest X-ray, no abnormality was detected. He had a travel history from Beijing 1 week before, and Physician suspects SARS CoV-2 virus infection in the patient. Which of the following samples should be collected for the RT-PCR test in this case?",
      "options": [
        {
          "label": "A",
          "text": "Blood",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Throat swab",
          "correct": true
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": false
        }
      ],
      "correct_answer": "C. Throat swab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Throat swab Sample collection for COVID-19 For RT-PCR: Oropharyngeal (throat) and nasopharyngeal swabs are the preferred samples collected using Dacron/polyester swabs dipped in viral transport media (VTM) after collection. The head should be tilted by 70 degrees while collecting NPS. Between OPS and NPS, the NPS has a higher sensitivity. Bronchoalveolar lavage or Endotracheal aspirate can be collected in the case of intubated patients. Rapid Antigen Test: Nasopharyngeal swab preferred</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Antibody detection: Blood/ serum Option B. There is no role of urine samples in laboratory diagnosis of COVID-19 Infection. Option D. Oropharyngeal (throat) and nasal/ nasopharyngeal swabs are the preferred samples. Option D is incorrect.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7d4ebba9",
      "audio": ""
    },
    {
      "text": "A 49-year-old man presents in medicine OPD with fever, sore throat and myalgia complaints. On examination, respiratory rate was 18/min, and oxygen saturation was 99%. In Chest X-ray, no abnormality was detected. He had a travel history from Beijing 1 week before, and Physician suspects SARS CoV-2 virus infection in the patient. Which of the following statements is incorrect regarding sample collection for COVID-19 sample collection?",
      "options": [
        {
          "label": "A",
          "text": "Oropharyngeal swabs and nasopharyngeal swabs are the preferred samples.",
          "correct": false
        },
        {
          "label": "B",
          "text": "N95 mask is essential for a sample collection from a suspected patient.",
          "correct": false
        },
        {
          "label": "C",
          "text": "For the transportation of samples, double-layer packing should be done.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sample should be dipped in Viral transport media after collection.",
          "correct": false
        }
      ],
      "correct_answer": "C. For the transportation of samples, double-layer packing should be done.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>For the transportation of samples, double-layer packing should be done. Samples collected for COVID-19 testing should be appropriately labelled, and a triple layer packaging method to be used for the transport of samples to the laboratory.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f524862c",
      "audio": ""
    },
    {
      "text": "A 26-year-old male was admitted to emergency high-grade fever and difficulty in breathing. On examination, the temperature was 102 F, and oxygen saturation was 40%. CT chest was suggestive of bilateral lung consolidation. Which of the following is the point of care test for diagnosis of COVID-19 so that appropriate treatment can be started timely?",
      "options": [
        {
          "label": "A",
          "text": "NAAT Nucleic Acid Amplification Test",
          "correct": false
        },
        {
          "label": "B",
          "text": "Antigen detection",
          "correct": true
        },
        {
          "label": "C",
          "text": "Antibody detection",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sequencing",
          "correct": false
        }
      ],
      "correct_answer": "B. Antigen detection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Antigen detection Point of care test is a test that can be conducted at a patient's bedside and gives rapid results. Antigen detection: For COVID-19, a r apid immunochromatography test is available for the qualitative detection of specific Nucleocapsid (N) protein of SARS CoV-2, which can be done at the patient's bedside . A nasopharyngeal swab is collected for this test, which is immersed in a viral extraction buffer. In the buffer, the virus is inactivated, and antigen is released. Test to be conducted within an hour, and the result is available within 15-30 minutes, depending on the kit used. However, the disadvantage of RAT Rapid Antigen Tests is that it has a low sensitivity (about 60 per cent)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Turn around time (TAT) for Nucleic Acid Amplification Test (NAAT) is 4-5 hours and is the gold standard test for COVID-19 diagnosis. Option C. Antibody (IgG) can be detected only after 1-2 weeks of infection, as antibodies appear late. Therefore, it should not be used for clinical diagnosis. Option D. Sequencing is not routinely used for diagnostic purposes but helps determine any mutation in the SARS-CoV-2 genome. Have an epidemiological advantage.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5beb8878",
      "audio": ""
    },
    {
      "text": "A 26-year-old male was admitted to emergency high-grade fever and difficulty in breathing. The temperature was 102 F on examination, and oxygen saturation was 40%. CT chest was suggestive of bilateral lung consolidation. Which of the following is the gold standard test for diagnosis of COVID-19?",
      "options": [
        {
          "label": "A",
          "text": "Real-time PCR",
          "correct": true
        },
        {
          "label": "B",
          "text": "Antigen detection",
          "correct": false
        },
        {
          "label": "C",
          "text": "Antibody detection",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sequencing",
          "correct": false
        }
      ],
      "correct_answer": "A. Real-time PCR",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Real-time PCR Laboratory tests for COVID-19 Types of COVID-19 Tests PCR Test Antigen Rapid Test (ART) Antibody/Serology Test Purpose of Test Diagnosis of active SARS-CoV-2 infection (COVID-19) Diagnosis of active SARS-CoV-2 infection (COVID-19) Check for past SARS-CoV-2 infection (COVID-19) Sample Type The sample is taken with a swab from the nose or mouth The sample is taken with a swab from the nose or mouth The blood sample is taken with a finger prick or venous blood draw Use of Test \u25cf       Symptomatic individuals \u25cf       Stay-Home Notice (SHN) exit swab \u25cf       Use of Test \u25cf       Quarantine Order (QO) entry and exit swab \u25cf       Rostered routine testing \u25cf       Screening for pre-event testing \u25cf       Rostered routine testing \u25cf       Differentiate between acute and old infections in cases that test positive for COVID-19 Turnaround Time As early as 24 hours after sample collection As early as 30 minutes after sample collection One to three weeks on average Limitations Unable to differentiate between acute and old infections \u25cf       Potentially high false-negative rate in individuals with low viral load \u25cf       Higher false positive rate than PCR tests Unable to rule out acute/early infection if the antibody test is negative 750 \u00d7 706</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a8217c7f",
      "audio": ""
    },
    {
      "text": "A 26-year-old male admitted in emergency high-grade fever and difficulty in breathing, on examination, the temperature was 102 F and oxygen saturation was 40%. CT chest was suggestive of bilateral lung consolidation. RT-PCR for COVID-19 is performed for diagnosis. Which of the following gene is targeted for confirmation of COVID-19 infection?",
      "options": [
        {
          "label": "A",
          "text": "M gene",
          "correct": false
        },
        {
          "label": "B",
          "text": "E gene",
          "correct": false
        },
        {
          "label": "C",
          "text": "S gene",
          "correct": false
        },
        {
          "label": "D",
          "text": "ORF1a/b",
          "correct": true
        }
      ],
      "correct_answer": "D. ORF1a/b",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>ORF1a/b Real-Time Polymerase Chain Reaction (RT PCR)/ Nucleic Acid Amplification Test (NAAT) is the gold standard test for COVID-19 diagnosis. Most of the kits target two genes in a single reaction-one for screening and the other for confirmation. #EXTRA-GENES FOR SARS COV2 CONFIRMATION Genes for confirmation- species-specific, i.e. SARS- CoV-2 RNA dependent RNA polymerase (RdRp) Open reducing frames (ORF1a/b) T he non-structural genes are used for confirmation as these are not shared by other Coronavirus. The structural genes have non-specific sharing. #EXTRA: SARS CoV-2 Structure</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "37e8c07c",
      "audio": ""
    },
    {
      "text": "A 26-year-old male admitted in high-grade emergency fever and difficulty in breathing, on examination, the temperature was 102 F, and oxygen saturation was 40%. CT chest was suggestive of bilateral lung consolidation. A rapid antigen test for COVID-19 was done, which was reported negative. Which of the following statements is true in this case?",
      "options": [
        {
          "label": "A",
          "text": "Treat him like a SARS-CoV-2 negative patient.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gene sequencing is the ideal choice for diagnosis.",
          "correct": false
        },
        {
          "label": "C",
          "text": "RT PCR for COVID-19 to be performed for confirmation.",
          "correct": true
        },
        {
          "label": "D",
          "text": "Repeat the Antigen assay with a different kit.",
          "correct": false
        }
      ],
      "correct_answer": "C. RT PCR for COVID-19 to be performed for confirmation.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>RT PCR for COVID-19 to be performed for confirmation. In the case mentioned above, the patient is symptomatic. Therefore RT PCR test should be performed Antigen detection assay: For COVID-19, a rapid immunochromatography test is available for the qualitative detection of specific Nucleocapsid (N) protein of SARS CoV-2, which can be done at the patient bedside (Point-of-care test). The test will be conducted within an hour, and the result will be available within 20-30 minutes.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f02dbfa1",
      "audio": ""
    },
    {
      "text": "A 26-year-old male was admitted to high-grade emergency fever and difficulty in breathing. The temperature was 102 F on examination, and oxygen saturation was 40%. CT chest was suggestive of bilateral lung consolidation. A rapid antigen test for COVID-19 was done, which was reported negative. The medical officer ordered RT PCR for COVID-19. What is the reason for the RT PCR test?",
      "options": [
        {
          "label": "A",
          "text": "COVID-19 Antigen assays have low specificity.",
          "correct": false
        },
        {
          "label": "B",
          "text": "COVID-19 Antigen assays have high specificity",
          "correct": false
        },
        {
          "label": "C",
          "text": "COVID-19 Antigen assays have low sensitivity",
          "correct": true
        },
        {
          "label": "D",
          "text": "COVID-19 Antigen assays have high sensitivity",
          "correct": false
        }
      ],
      "correct_answer": "C. COVID-19 Antigen assays have low sensitivity",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>COVID-19 Antigen assays have low sensitivity For COVID-19, a rapid immunochromatography test for Antigen assay is available for the qualitative detection of specific Nucleocapsid (N) protein of SARS CoV-2, which can be done at the patient bedside (Point-of-care test). Test to be conducted within an hour; the result is available within 20-30 minutes. It is highly specific (99-100%)[OPTION A AND B] but less sensitive (50-84%) [OPTION C AND D]. Therefore, RT PCR should be done for symptomatic Antigen negative patients to confirm the diagnosis.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- So, Options A, B and D. Are not the correct options.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0804e87",
      "audio": ""
    },
    {
      "text": "For COVID-19, Chemiluminescence for detection of IgG antibodies is available. Antibody detection for COVID-19 is for:",
      "options": [
        {
          "label": "A",
          "text": "Clinical diagnosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Point of care test",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sero-surveillance",
          "correct": true
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": false
        }
      ],
      "correct_answer": "C. Sero-surveillance",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Sero-surveillance For IgG detection, various tests like ELISA, Immunochromatographic and chemiluminescence tests are available. As IgG Antibodies appear late (after 2 weeks of infection), this test is not useful for definitive diagnosis of patients. Uses of Antibodies detection in case of COVID-19: Sero-surveillance of the exposed population, including asymptomatic patients, to implement prevention and control of infection For survey in health care workers, immunocompromised, and other front-line workers to know the status of infection.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. For Clinical diagnosis, the RT PCR test is the gold standard test. Option B. Another test that can be used for diagnosis is the Rapid Antigen assay, a point-of-care test that can be performed at the patient's bedside. Option D. Option D is incorrect as Antibody detection can be used only for serosurveillance, not for clinical diagnosis or as a point-of-care test.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5f0eaa59",
      "audio": ""
    },
    {
      "text": "There are various COVID-19 vaccines available and effective in Phase III clinical trials. Which of the following vaccines have viruses as vectors to generate an immune response?",
      "options": [
        {
          "label": "A",
          "text": "Covishield",
          "correct": true
        },
        {
          "label": "B",
          "text": "Covaxin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Moderna",
          "correct": false
        },
        {
          "label": "D",
          "text": "ZyCoV-d",
          "correct": false
        }
      ],
      "correct_answer": "A. Covishield",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Covishield Covishield is viral vector medicine that uses chimpanzee Adenovirus, a safe non-replicating virus that can not produce disease but produces coronavirus proteins. These coronavirus proteins generate an immune response and provide immunity. Other examples of viral vector vaccines for COVID-19 are AstraZeneca, Sputnik V and Johnson & Johnson.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B. uses Inactivated virus, which cannot cause disease but generates an immune response. Option C. Moderna is an mRNA-based vaccine. Option D. ZyCoV-D is DNA based vaccine Other vaccines: Novivax: protein-based vaccine</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9cd5096",
      "audio": ""
    },
    {
      "text": "In India, 2 vaccines are licensed for use in a phased manner. Which of the following statements is incorrect about COVID-19 VACCINATION IN INDIA?",
      "options": [
        {
          "label": "A",
          "text": "Uses non-replicating modified chimpanzee Adenovirus as a vector.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Covid-19 vaccine is administered in two doses by IM route.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Recovered COVID-19 patients can also have vaccines.",
          "correct": false
        },
        {
          "label": "D",
          "text": "To be stored at -80 degrees Celsius only.",
          "correct": true
        }
      ],
      "correct_answer": "D. To be stored at -80 degrees Celsius only.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>To be stored at -80 degrees Celsius only. Two vaccines are licensed in India- Covishield and Covaxin, which need to be stored at 2-8 degrees Celsius. Pfizer vaccine needs storage at -90 to -60 degrees Celsius as its an mRNA vaccine.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A. Covishield- viral vector medicine, uses modified Chimpanzee Adenovirus, a safe non-replicating virus that can not produce disease but produces coronavirus proteins. These coronavirus proteins generate an immune response and provide immunity. Other examples of viral vector vaccines for COVID-19 are AstraZeneca, Sputnik V and Johnson & Johnson. Covaxin: Inactivated whole virion vaccine, which cannot cause disease but generates an immune response. Option B. Both licensed vaccines in India are administered in two doses by IM route a minimum 4 weeks apart.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "af2667cb",
      "audio": ""
    }
  ]
}